DIMENSIONAL FUND ADVISORS LP

Position in PRAX — Praxis Precision Medicines, Inc.

CIK 354204 AUSTIN, TX

Position in PRAX

as of Mar 31, 2026 · filed May 7, 2026 Compact

Position Value

$10,039,762

+$3,100,699 QoQ

Shares Held

31,161

+32.4% QoQ

Ownership

0.112%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

DIMENSIONAL FUND ADVISORS LP holds $5,003,215,874 across 223 Biotechnology names. PRAX ranks #75 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	989,342	$441,780,774
2	REGN	Regeneron Pharmaceuticals, Inc.	513,060	$396,410,676
3	JAZZ	Jazz Pharmaceuticals plc	1,895,215	$358,290,394
4	BMRN	Biomarin Pharmaceutical Inc	3,802,930	$214,827,514
5	ROIV	Roivant Sciences Ltd.	7,475,866	$207,081,486
6	INCY	Incyte Corp	1,975,544	$185,938,199
7	EXEL	Exelixis, Inc.	4,299,597	$184,409,714
8	HALO	Halozyme Therapeutics, Inc.	2,079,827	$134,419,216

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$10,039,762	31,161	+32.4%	Shares	Sole	2026-05-07
2025-12-31	$6,939,063	23,543	-37.1%	Shares	Sole	2026-02-12
2025-09-30	$1,982,942	37,414	+723.4%	Shares	Sole	2025-11-12
2024-12-31	$349,705	4,544	-10.7%	Shares	Sole	2025-02-13
2024-09-30	$292,820	5,089	-26.1%	Shares	Sole	2024-11-07
2024-06-30	$284,886	6,888	-54.2%	Shares	Sole	2024-08-09
2024-03-31	$917,740	15,040	+9.7%	Shares	Sole	2024-05-10
2023-12-31	$305,457	13,710	—	Shares	Sole	2024-02-07
No filing history on record for this holder in this stock.